Jun 222017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced that in line with Ocular's strategic plan and growth objectives, Antony Mattessich will succeed Dr.=> Read more

Ocular Therapeutix announces Antony Mattessich as upcoming CEO alongside Dr Amar Sawhney as Executive Chairman

From:: Ocular Therapeutix announces Antony Mattessich as upcoming CEO alongside Dr Amar Sawhney as Executive Chairman

Sorry, the comment form is closed at this time.

%d bloggers like this: